Cell and Gene Commercialization

31. Advanced Manufacturing And CDMOs Are Rewriting The CGT Cost Equation 7/16/2025

    Without contract manufacturers, small biotechs often don't stand a chance of reaching commercial production scales, let alone global access for their drugs.

32. Redefining CGT With Exosomes And EVs 7/16/2025

    July’s Cell & Gene Live featured a comprehensive look at the scientific advances, clinical promise, manufacturing hurdles, and regulatory considerations shaping extracellular vesicle and exosome-based therapies. 

33. Ori Spotlight: Investor Confidence In Advanced Therapies Is Critical For Long-Term Success 7/9/2025

    Endpoints News founder Arsalan Arif shares his journey and unpacks the cell and gene therapy market, from investor sentiment to the challenges of scaling innovation.

34. Commercializing Your First CGT: Developing Your Market Access Strategy 7/2/2025

    Effectively commercializing cell and gene therapies requires a strong market access strategy. Learn key steps for ensuring your therapy reaches patients at the right time and place.

35. Integrated Services: Expertise At Every Step 7/2/2025

    Bringing cell and gene therapies to market is complex, but with the right partner, you can overcome challenges and simplify, support, and scale your therapy from development to commercialization.

36. How CGT Leaders Are Reducing Failures, Scaling Processes, And Overcoming Regulatory Friction 6/30/2025

     Industry leaders share their philosophy on reducing product failure, embracing AI, and building dynamic teams to stay ahead of the curve to bring curative CGT therapies to patients.

37. Ori Spotlight: How Early Automation Strategies Reduce Costs And Improve Patient Access 6/20/2025

    A pioneer in regenerative medicine reveals how to bridge the gap from research to reality. Learn how early automation and strategic partnerships can slash costs and expand patient access to therapies.

38. Perspectives And Projections On The 2025 Biotech Landscape 6/13/2025

    Listen to Aditya Kotta discuss key biotech trends, from post-COVID market shifts to global R&D and investment strategies, as well as China’s rising role in pharmaceutical innovation.

39. Amgen Bets On Agility In The Age Of AI 6/13/2025

    The company is speeding up process optimization with tools like predictive analytics, digital twins, and generative AI copilots.

40. Crafting Scalable Solutions For Maximum Reach And Success 6/12/2025

    Is your supply chain ready for a blockbuster cell and gene therapy launch? Industry leaders discuss selecting partners, managing risk, and scaling operations for maximum reach and success.